Jiaqi Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jiaqi Wang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Cuiying Li
Department of Blood Transfusion Air Force Medical Center Beijing China
1 shared publication- Cuiying Li
Department of Blood Transfusion, Air Force Medical Center, Air Force Medical University, Beijing, China
1 shared publication Daoju Ren
Department of Blood Transfusion Air Force Medical Center Beijing China
1 shared publication- Daoju Ren
Department of Blood Transfusion, Air Force Medical Center, Air Force Medical University, Beijing, China
1 shared publication - Huifen Lei
Department of Blood Transfusion, Air Force Medical Center, Air Force Medical University, Beijing, China
1 shared publication - Huimin Li
Department of Blood Transfusion, Air Force Medical Center, Air Force Medical University, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 24 August 2026
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
Precision in Prenatal Testing: Noninvasive Detection of Fetal ABO Blood Groups
Daoju Ren, M.S., Cuiying Li, M.S., Xiaowei Li, M.D., Jun Xiao, M.D., Huifen Lei, M.S., Zhicai Li, M.S., Jiaqi Wang, M.S., Huimin Li, B.S. and Xiaoying Bai, B.S.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2026.0286
- 24 August 2026
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
Open AccessPrecision in Prenatal Testing: Noninvasive Detection of Fetal ABO Blood Groups
Daoju Ren, M.S., Cuiying Li, M.S., Xiaowei Li, M.D., Jun Xiao, M.D., Huifen Lei, M.S., Zhicai Li, M.S., Jiaqi Wang, M.S., Huimin Li, B.S. and Xiaoying Bai, B.S.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2026.0286
- 18 May 2026
- Published by Wiley in Journal of Cellular Physiology
- Vol. 241 (5) , e70190
Unveiling the VEGFR2–TTI1–mTORC1 Axis: A Crucial Pathway in Hypoxia‐Induced Erythropoiesis
Erythropoiesis is a meticulously regulated process influenced by a multitude of factors. Prior research has demonstrated that hypoxic conditions (5% O 2 ) facilitate erythroid differentiation. Nevertheless, although our preliminary data indicate the involvement of VEGF/VEGFR2 in this process, the precise regulatory mechanism in erythropoiesis under hypoxia remains inadequately understood. In this study, an in vitro model of inhibited erythroid differentiation was developed using CD34 + hematopoietic stem cells treated with a VEGFR2‐neutralizing antibody. Additionally, the signaling axis was modulated under hypoxia conditions employing the mTOR inhibitor rapamycin and TTI1 ‐siRNA. The findings revealed that hypoxia significantly upregulated VEGF/VEGFR2 expression and promoted erythroid differentiation. Conversely, VEGFR2 inhibition resulted in a substantial decrease in erythroid surface markers and hemoglobin synthesis. Proteomics analysis suggested that TTI1 and mTOR are pivotal components of this signaling axis, with their suppression effectively impeding erythropoiesis. Under hypoxic conditions, VEGFR2 may regulate erythroid differentiation of CD34 + cells through a mechanism involving the TTI1–mTORC1 signaling pathway.
- 18 May 2026
- Published by Wiley in Journal of Cellular Physiology
- Vol. 241 (5) , e70190
Unveiling the VEGFR2–TTI1–mTORC1 Axis: A Crucial Pathway in Hypoxia‐Induced Erythropoiesis
Erythropoiesis is a meticulously regulated process influenced by a multitude of factors. Prior research has demonstrated that hypoxic conditions (5% O 2 ) facilitate erythroid differentiation. Nevertheless, although our preliminary data indicate the involvement of VEGF/VEGFR2 in this process, the precise regulatory mechanism in erythropoiesis under hypoxia remains inadequately understood. In this study, an in vitro model of inhibited erythroid differentiation was developed using CD34 + hematopoietic stem cells treated with a VEGFR2‐neutralizing antibody. Additionally, the signaling axis was modulated under hypoxia conditions employing the mTOR inhibitor rapamycin and TTI1 ‐siRNA. The findings revealed that hypoxia significantly upregulated VEGF/VEGFR2 expression and promoted erythroid differentiation. Conversely, VEGFR2 inhibition resulted in a substantial decrease in erythroid surface markers and hemoglobin synthesis. Proteomics analysis suggested that TTI1 and mTOR are pivotal components of this signaling axis, with their suppression effectively impeding erythropoiesis. Under hypoxic conditions, VEGFR2 may regulate erythroid differentiation of CD34 + cells through a mechanism involving the TTI1–mTORC1 signaling pathway.